nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2C19—urine—polycystic ovary syndrome	0.0378	0.0916	CbGeAlD
Methazolamide—CYP2C9—urine—polycystic ovary syndrome	0.0293	0.071	CbGeAlD
Methazolamide—CYP2E1—urine—polycystic ovary syndrome	0.0278	0.0673	CbGeAlD
Methazolamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0259	0.0627	CbGeAlD
Methazolamide—CYP3A4—urine—polycystic ovary syndrome	0.0223	0.0542	CbGeAlD
Methazolamide—CYP2D6—urine—polycystic ovary syndrome	0.022	0.0533	CbGeAlD
Methazolamide—CA14—adrenal gland—polycystic ovary syndrome	0.0165	0.0401	CbGeAlD
Methazolamide—CA9—endocrine gland—polycystic ovary syndrome	0.0151	0.0367	CbGeAlD
Methazolamide—CA5B—adipose tissue—polycystic ovary syndrome	0.0129	0.0313	CbGeAlD
Methazolamide—CA5B—adrenal gland—polycystic ovary syndrome	0.0116	0.028	CbGeAlD
Methazolamide—CA1—adipose tissue—polycystic ovary syndrome	0.0114	0.0276	CbGeAlD
Methazolamide—CA2—embryo—polycystic ovary syndrome	0.0112	0.0271	CbGeAlD
Methazolamide—CA12—endocrine gland—polycystic ovary syndrome	0.0112	0.0271	CbGeAlD
Methazolamide—CA5B—vagina—polycystic ovary syndrome	0.0107	0.026	CbGeAlD
Methazolamide—CA5B—endocrine gland—polycystic ovary syndrome	0.01	0.0243	CbGeAlD
Methazolamide—CA2—adrenal cortex—polycystic ovary syndrome	0.00917	0.0222	CbGeAlD
Methazolamide—CA4—pituitary gland—polycystic ovary syndrome	0.00894	0.0217	CbGeAlD
Methazolamide—CA4—adipose tissue—polycystic ovary syndrome	0.0089	0.0216	CbGeAlD
Methazolamide—CA1—endocrine gland—polycystic ovary syndrome	0.00886	0.0215	CbGeAlD
Methazolamide—CA4—adrenal gland—polycystic ovary syndrome	0.00799	0.0194	CbGeAlD
Methazolamide—CA4—female gonad—polycystic ovary syndrome	0.00745	0.0181	CbGeAlD
Methazolamide—CA2—pituitary gland—polycystic ovary syndrome	0.00741	0.018	CbGeAlD
Methazolamide—CA2—adipose tissue—polycystic ovary syndrome	0.00738	0.0179	CbGeAlD
Methazolamide—CA4—endocrine gland—polycystic ovary syndrome	0.00693	0.0168	CbGeAlD
Methazolamide—CYP2C19—vagina—polycystic ovary syndrome	0.0067	0.0162	CbGeAlD
Methazolamide—CA2—adrenal gland—polycystic ovary syndrome	0.00662	0.0161	CbGeAlD
Methazolamide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00627	0.0152	CbGeAlD
Methazolamide—CA2—female gonad—polycystic ovary syndrome	0.00617	0.015	CbGeAlD
Methazolamide—CA2—vagina—polycystic ovary syndrome	0.00614	0.0149	CbGeAlD
Methazolamide—CA2—endocrine gland—polycystic ovary syndrome	0.00574	0.0139	CbGeAlD
Methazolamide—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00531	0.0129	CbGeAlD
Methazolamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00486	0.0118	CbGeAlD
Methazolamide—CYP2E1—endocrine gland—polycystic ovary syndrome	0.0046	0.0112	CbGeAlD
Methazolamide—CYP2D6—female gonad—polycystic ovary syndrome	0.00392	0.0095	CbGeAlD
Methazolamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0037	0.00898	CbGeAlD
Methazolamide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00365	0.00884	CbGeAlD
Methazolamide—CA1—Metabolism—TH—polycystic ovary syndrome	0.000371	0.000631	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000369	0.000628	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000366	0.000622	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000362	0.000616	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000362	0.000616	CbGpPWpGaD
Methazolamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000361	0.000614	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000359	0.00061	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000357	0.000607	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000354	0.000602	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000354	0.000602	CbGpPWpGaD
Methazolamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000348	0.000592	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000346	0.000589	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000341	0.00058	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000339	0.000577	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000334	0.000569	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000332	0.000565	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00033	0.000562	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00033	0.000562	CbGpPWpGaD
Methazolamide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.00033	0.000561	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000329	0.00056	CbGpPWpGaD
Methazolamide—CA14—Metabolism—INS—polycystic ovary syndrome	0.000328	0.000558	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000326	0.000555	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.000326	0.000555	CbGpPWpGaD
Methazolamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000326	0.000555	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000324	0.000552	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000324	0.000552	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000323	0.00055	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000323	0.000549	CbGpPWpGaD
Methazolamide—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000321	0.000547	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000321	0.000547	CbGpPWpGaD
Methazolamide—CA6—Metabolism—INS—polycystic ovary syndrome	0.00032	0.000544	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.00032	0.000544	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000318	0.000542	CbGpPWpGaD
Methazolamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000317	0.00054	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000316	0.000539	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000316	0.000539	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000316	0.000537	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000315	0.000537	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000314	0.000534	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000312	0.000532	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000304	0.000518	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000304	0.000518	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	0.000303	0.000515	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000301	0.000512	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000301	0.000512	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.0003	0.000511	CbGpPWpGaD
Methazolamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.0003	0.000511	CbGpPWpGaD
Methazolamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000298	0.000508	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000298	0.000508	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000298	0.000507	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000297	0.000506	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000294	0.000501	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000294	0.000501	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000293	0.000499	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000293	0.000499	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000291	0.000495	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000291	0.000495	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000289	0.000493	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000289	0.000491	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000289	0.000491	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	0.000288	0.000491	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000288	0.000489	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000285	0.000485	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000285	0.000485	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000282	0.00048	CbGpPWpGaD
Methazolamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000278	0.000473	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000277	0.000472	CbGpPWpGaD
Methazolamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000276	0.000471	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000273	0.000465	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000272	0.000462	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000271	0.000461	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.00027	0.000459	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000268	0.000457	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000268	0.000457	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000267	0.000455	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000266	0.000453	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000266	0.000452	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000262	0.000446	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000258	0.000438	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000255	0.000434	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000255	0.000433	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000253	0.000431	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.00025	0.000426	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.00025	0.000426	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000246	0.000418	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000245	0.000417	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000241	0.000409	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.00024	0.000409	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000237	0.000403	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000237	0.000403	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000233	0.000397	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000232	0.000395	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.00023	0.000392	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.00023	0.000392	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000228	0.000388	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000228	0.000388	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000225	0.000383	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000224	0.000381	CbGpPWpGaD
Methazolamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000222	0.000377	CbGpPWpGaD
Methazolamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.00022	0.000375	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000219	0.000373	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000219	0.000373	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000216	0.000367	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000216	0.000367	CbGpPWpGaD
Methazolamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000213	0.000362	CbGpPWpGaD
Methazolamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000211	0.00036	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.00021	0.000357	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000209	0.000356	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000208	0.000354	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	0.000207	0.000352	CbGpPWpGaD
Methazolamide—CA1—Metabolism—POMC—polycystic ovary syndrome	0.000204	0.000347	CbGpPWpGaD
Methazolamide—CA1—Metabolism—INS—polycystic ovary syndrome	0.000203	0.000345	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000199	0.000338	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000193	0.000328	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000191	0.000325	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000191	0.000324	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00019	0.000324	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00019	0.000324	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.00019	0.000323	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000187	0.000319	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000186	0.000317	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000183	0.000311	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.000182	0.000309	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000181	0.000308	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00018	0.000307	CbGpPWpGaD
Methazolamide—CA9—Metabolism—POMC—polycystic ovary syndrome	0.000179	0.000305	CbGpPWpGaD
Methazolamide—CA9—Metabolism—INS—polycystic ovary syndrome	0.000178	0.000303	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000177	0.000301	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000176	0.0003	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000174	0.000297	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000173	0.000294	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000171	0.000291	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000169	0.000288	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000166	0.000282	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000161	0.000274	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000161	0.000274	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000159	0.000271	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000155	0.000265	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000155	0.000264	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000154	0.000262	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000151	0.000257	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00015	0.000256	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00015	0.000256	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000149	0.000253	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000148	0.000252	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000147	0.00025	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000147	0.00025	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000147	0.00025	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000145	0.000247	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000144	0.000245	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000139	0.000237	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000139	0.000236	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000138	0.000234	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000137	0.000233	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000135	0.00023	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000134	0.000228	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000132	0.000225	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000131	0.000223	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000128	0.000218	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000128	0.000218	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000127	0.000216	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000126	0.000215	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000124	0.000211	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.00012	0.000203	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000119	0.000203	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000118	0.000201	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000118	0.0002	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000117	0.000199	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000115	0.000195	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000114	0.000194	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000114	0.000194	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000114	0.000194	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000113	0.000193	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.00011	0.000187	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000109	0.000186	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000108	0.000184	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000107	0.000182	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000106	0.00018	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000105	0.000179	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000105	0.000178	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000104	0.000178	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000104	0.000177	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000103	0.000176	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000103	0.000175	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000102	0.000173	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	9.85e-05	0.000168	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.77e-05	0.000166	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	9.7e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.69e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	9.65e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	9.61e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	9.2e-05	0.000157	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	9.12e-05	0.000155	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	8.88e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.84e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	8.72e-05	0.000148	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.64e-05	0.000147	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	8.39e-05	0.000143	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.37e-05	0.000142	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	8.34e-05	0.000142	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	8.32e-05	0.000142	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.16e-05	0.000139	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	8.13e-05	0.000138	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	8.09e-05	0.000138	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.7e-05	0.000131	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	7.68e-05	0.000131	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.61e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.46e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	7.45e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.19e-05	0.000122	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	7.1e-05	0.000121	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.91e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.85e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.82e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.79e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	6.73e-05	0.000114	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	6.59e-05	0.000112	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	6.53e-05	0.000111	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	6.5e-05	0.000111	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	6.47e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—INS—polycystic ovary syndrome	6.46e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.34e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	6.27e-05	0.000107	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.19e-05	0.000105	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	6.13e-05	0.000104	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.77e-05	9.82e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.72e-05	9.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.49e-05	9.34e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.34e-05	9.08e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.08e-05	8.65e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.02e-05	8.54e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.02e-05	8.54e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.99e-05	8.49e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.68e-05	7.96e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.64e-05	7.89e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.61e-05	7.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.59e-05	7.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.57e-05	7.78e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.55e-05	7.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.48e-05	7.62e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.27e-05	7.26e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.04e-05	6.88e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.77e-05	6.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.06e-05	5.2e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.02e-05	5.13e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3e-05	5.1e-05	CbGpPWpGaD
